SSY Group Limited (HKG:2005)

Market Cap	7.05B -28.4%
Revenue (ttm)	4.17B -27.8%
Net Income	470.64M -55.6%
EPS	0.16 -55.2%
Shares Out	2.90B
PE Ratio	15.14
Forward PE	12.14
Dividend	0.08 (3.29%)
Ex-Dividend Date	May 20, 2026

Volume	5,170,000
Average Volume	7,683,379
Open	2.420
Previous Close	2.430
Day's Range	2.400 - 2.440
52-Week Range	2.350 - 3.400
Beta	0.52
RSI	40.52
Earnings Date	Mar 27, 2026

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,700
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2025, SSY Group's revenue was 4.17 billion, a decrease of -27.85% compared to the previous year's 5.77 billion. Earnings were 470.64 million, a decrease of -55.65%.